Safety Matters Market need: Encision’s AEM shield products address preventable intraoperative stray energy burns in laparoscopic surgery, suggesting strong demand from hospitals and surgical centers aiming to reduce patient risk and liability.

Robot Adoption Opportunity: Declining revenue tied to surgical robots performing procedures indicates a transition in the market. Position Encision as a complementary safety solution for robot-assisted laparoscopic systems to protect patients during minimally invasive surgeries.

New ENT Device Product expansion: Funding that supported a planned early-2026 ENT device launch presents a potential cross-sell or upsell path for existing AEM users and new customers seeking comprehensive intraoperative safety tech.

Strategic Funding Financing cues: Recent private placement and working capital activity imply availability of growth capital and a willingness to invest in commercialization efforts, enabling targeted outreach to strategic hospital networks and distributors.

Public/Private Path Market access: Transition from deregistration and OTC trading volatility suggests evaluating alternative distribution and market access strategies, including partnerships with medical device distributors and direct hospital sales teams to stabilize revenue streams.